News
Important Only
Well Health Announces Availability For 45,000 New Primary Care Patients Across 3 Provinces Enabled By Investments In Physician Recruitment And Digital Transformation
June 24 (Reuters) - WELL Health Technologies Corp WELL.TO:WELL HEALTH ANNOUNCES AVAILABILITY FOR 45,000 NEW PRIMARY CARE PATIENTS ACROSS 3 PROVINCES ENABLED BY INVESTMENTS IN PHYSICIAN RECRUITMENT AND DIGITAL TRANSFORMATIONReuters
Tue, Jun 24
Cheniere Announces Positive Final Investment Decision On The Corpus Christi Midscale Trains 8 & 9 Project And Updated Company Outlook Through 2030
June 24 (Reuters) - Cheniere Energy Inc LNG.N:CHENIERE ANNOUNCES POSITIVE FINAL INVESTMENT DECISION ON THE CORPUS CHRISTI MIDSCALE TRAINS 8 & 9 PROJECT AND UPDATED COMPANY OUTLOOK THROUGH 2030CHENIERE ENERGY INC - PLANS TO INCREASE DIVIDEND BY OVER 10% TO $2.22 PER SHARE FOR Q3CHENIERE ENERGY IN...Reuters
Tue, Jun 24
United Therapeutics And Intermountain Health Announce The First Patient Treated With External Liver Support Using A Bioengineered Liver
June 24 (Reuters) - United Therapeutics Corp UTHR.O:UNITED THERAPEUTICS AND INTERMOUNTAIN HEALTH ANNOUNCE THE FIRST PATIENT TREATED WITH EXTERNAL LIVER SUPPORT USING A BIOENGINEERED LIVERReuters
Tue, Jun 24
Krystal Biotech Announces First Patient Dosed In Phase 3 Clinical Trial Of Kb803 For The Treatment And Prevention Of Corneal Abrasions
June 24 (Reuters) - Krystal Biotech Inc KRYS.O:KRYSTAL BIOTECH ANNOUNCES FIRST PATIENT DOSED IN PHASE 3 CLINICAL TRIAL OF KB803 FOR THE TREATMENT AND PREVENTION OF CORNEAL ABRASIONS IN PATIENTS WITH DYSTROPHIC EPIDERMOLYSIS BULLOSAReuters
Tue, Jun 24
Recordati Signs Exclusive Licensing & Supply Agreement With Amarin To Commercialize Vazkepa In Europe
June 24 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA RECI.MI:RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA IN EUROPERECORDATI TO PAY AMARIN AN UPFRONT CASH PAYMENT OF US$ 25 MILLIONAMARIN TO SUPPLY FINISHED PRODUCT TO RECORDATI, IS ...Reuters
Tue, Jun 24
The U.S. Food And Drug Administration Completes Review Of Cibus’ Altered Lignin Alfalfa
June 24 (Reuters) - Cibus Inc CBUS.O:THE U.S. FOOD AND DRUG ADMINISTRATION COMPLETES REVIEW OF CIBUS’ ALTERED LIGNIN ALFALFA DEVELOPED IN PARTNERSHIP WITH S&W SEED COMPANY FOR USE IN LIVESTOCK FEEDCIBUS INC - FDA HAS NO FURTHER QUESTIONS ON ALTERED LIGNIN ALFALFAReuters
Tue, Jun 24
Tilray Medical Receives Italy’S First Authorization From The Ministry Of Health To Distribute Medical Cannabis Flower For Therapeutic Use
June 24 (Reuters) - Tilray Brands Inc TLRY.O:TILRAY MEDICAL RECEIVES ITALY’S FIRST AUTHORIZATION FROM THE MINISTRY OF HEALTH TO DISTRIBUTE MEDICAL CANNABIS FLOWER FOR THERAPEUTIC USEReuters
Tue, Jun 24
Revolution Medicines Enters Into $2 Billion Flexible Funding Agreement With Royalty Pharma
June 24 (Reuters) - Revolution Medicines Inc RVMD.O:REVOLUTION MEDICINES ENTERS INTO $2 BILLION FLEXIBLE FUNDING AGREEMENT WITH ROYALTY PHARMA TO SUPPORT GLOBAL DEVELOPMENT AND COMMERCIALIZATION OF RAS(ON) INHIBITOR PORTFOLIO FOR PATIENTS WITH RAS-ADDICTED CANCERSREVOLUTION MEDICINES INC - TERM LOAN...Reuters
Tue, Jun 24
Iridex Announces First Patient Enrolled In An Independent Landmark Investigator
June 24 (Reuters) - IRIDEX Corp IRIX.O:IRIDEX ANNOUNCES FIRST PATIENT ENROLLED IN AN INDEPENDENT LANDMARK INVESTIGATOR-LED UK STUDY EVALUATING MICROPULSE® TECHNOLOGY AS AN ADJUNCT TO ANTI-VEGF THERAPY FOR DIABETIC MACULAR EDEMAReuters
Tue, Jun 24
Turkey's Erdogan seeks lifting of NATO defence trade limitations
ANKARA, June 24 (Reuters) - Turkish President Tayyip Erdogan said on Tuesday that defence trade limitations between NATO countries should be lifted unconditionally, adding that Turkey wanted to host the NATO summit in 2026.Speaking at a press conference in Ankara before flying to The Hague to attend...Reuters
Tue, Jun 24
Array Technologies Announces Proposed Private Offering Of $250 Million Of New Convertible Senior Notes
June 24 (Reuters) - Array Technologies Inc ARRY.O:ARRAY TECHNOLOGIES ANNOUNCES PROPOSED PRIVATE OFFERING OF $250 MILLION OF NEW CONVERTIBLE SENIOR NOTESARRAY TECHNOLOGIES INC - TO USE PROCEEDS TO REPAY $150 MILLION TERM LOANReuters
Tue, Jun 24
Amarin Announces Exclusive License And Supply Agreement With Recordati
June 24 (Reuters) - Amarin Corporation PLC AMRN.O:AMARIN ANNOUNCES EXCLUSIVE LICENSE AND SUPPLY AGREEMENT WITH RECORDATI TO COMMERCIALIZE VAZKEPA® (ICOSAPENT ETHYL) IN EUROPEAMARIN CORPORATION PLC - TO RECEIVE $25 MILLION UPFRONT, UP TO $150 MILLION IN MILESTONESAMARIN CORPORATION PLC - TO STREAMLIN...Reuters
Tue, Jun 24
Ibio And Astralbio Unveil Obesity Program With Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results
June 24 (Reuters) - iBio Inc IBIO.O:IBIO AND ASTRALBIO UNVEIL OBESITY PROGRAM WITH NOVEL AMYLIN AGONIST ANTIBODY DEMONSTRATING PROMISING IN VIVO RESULTSIBIO INC - ANTIBODY-BASED AGONISTS SHOW POTENTIAL FOR OBESITY AND CARDIOMETABOLIC DISEASESIBIO INC - AMYLIN RECEPTOR AGONIST ANTIBODY REDUCES FOOD I...Reuters
Tue, Jun 24
